YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
Status:
Completed
Trial end date:
2018-07-03
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety profile of YAZ in Chinese women, including
adverse drug reactions (ADRs).
The secondary objectives are to investigate the rate of unintended pregnancies, the cycle
control for subjects with and without preceding abortion, the bleeding pattern of subjects
with and without preceding abortion (including the abortion-related bleeding pattern) and the
efficacy in moderate acne vulgaris.
Another objective is to investigate the effect on dysmenorrhea.